Filing
Spy
Filing
Spy
Home
About
ZNTL
Zentalis Pharmaceuticals Inc
Clinical-stage biopharmaceutical company
CUSIP: 98943L107
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2022 Q1
2 of 9 quarters
Total Value
$93.51M
Total Shares
2.03M
Net Share Change
-91.6K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$93.51M
2.03M
0.4%
TRIM
-91.6K
(-4.3%)
Viking Global Investors
$93.51M
2.03M shares
TRIM
-91.6K
(-4.3%)
ZNTL — Zentalis Pharmaceuticals Inc - FilingSpy